As a pharmaceutical company with a significant global footprint, we are well aware that we have a serious responsibility – to aid in reducing the considerable burden of disease on individuals and on the world. We aim to achieve this by focusing on generating solutions that make medicines affordable to all, coupled with innovation at every stage of our processes.

All our three businesses, Global Generics, Pharmaceutical Services & Active Ingredients (PSAI) and Proprietary Products address affordability in different ways. And, innovation underpins our efforts to create affordability and access to medicines in each business in a unique manner.